标题
Montelukast as a potential treatment for COVID-19
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 24, Issue 5, Pages 551-555
出版商
Informa UK Limited
发表日期
2023-03-17
DOI
10.1080/14656566.2023.2192866
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19)
- (2022) Matthew W. McCarthy EXPERT OPINION ON PHARMACOTHERAPY
- Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
- (2022) Francisco Mera-Cordero et al. Trials
- Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients
- (2022) Marina Camera et al. Frontiers in Pharmacology
- Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
- (2022) Max Luedemann et al. Computational and Structural Biotechnology Journal
- A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial
- (2022) Hossein Esmaeilzadeh et al. American Journal of Rhinology & Allergy
- Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJ
- (2022) Yun Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator
- (2022) Yongkang Chen et al. Viruses-Basel
- The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID‐19‐ related cough: A randomized, controlled clinical trial
- (2022) Rasool Soltani et al. Clinical Respiratory Journal
- Regulatory T Cells, a Viable Target Against Airway Allergic Inflammatory Responses in Asthma
- (2022) Jing Zhang et al. Frontiers in Immunology
- Biologics in severe asthma: the role of real-world evidence from registries
- (2022) Giovanni Paoletti et al. European Respiratory Review
- Guidance for Administering Biologics for Severe Asthma and Allergic Conditions
- (2022) Delbert R. Dorscheid et al. Canadian Respiratory Journal
- Treatment of severe COVID-19: an evolving paradigm
- (2022) Matthew W McCarthy EXPERT OPINION ON PHARMACOTHERAPY
- Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19
- (2022) Susanna Naggie et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
- (2022) Cátia F. Marques et al. Pharmaceuticals
- Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
- (2021) Rogan A. Grant et al. NATURE
- Collaborative platform trials to fight COVID‐19: methodological and regulatory considerations for a better societal outcome
- (2021) Olivier Collignon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Montelukast in hospitalized patients diagnosed with COVID-19
- (2021) Ahsan R. Khan et al. JOURNAL OF ASTHMA
- Asma en pediatría: consenso REGAP
- (2021) Luis Moral et al. ANALES DE PEDIATRIA
- Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
- (2021) Hayder M. Al-kuraishy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of using montelukast during acute wheezing attack in hospitalized preschool children on the discharge rate and the clinical asthma score
- (2021) Emine Demet Akbaş et al. PEDIATRIC PULMONOLOGY
- Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics
- (2021) Lisa LaVange et al. ANNALS OF INTERNAL MEDICINE
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support–free days
- (2021) Anthony A. Donato ANNALS OF INTERNAL MEDICINE
- Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID‐19
- (2021) Buğra Kerget et al. JOURNAL OF MEDICAL VIROLOGY
- The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
- (2021) Serdar Durdagi et al. MOLECULAR THERAPY
- Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing
- (2021) Anca Zanfirescu et al. Pharmaceuticals
- Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
- (2020) Francis S. Collins et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Montelukast's ability to fight COVID-19 infection
- (2020) Andrzej Bozek et al. JOURNAL OF ASTHMA
- Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms
- (2020) Nitesh Sanghai et al. DRUG DISCOVERY TODAY
- Adipose Tissue-Derived Mesenchymal Stem Cell Modulates the Immune Response of Allergic Rhinitis in a Rat Model
- (2019) Nesrine Ebrahim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug
- (2019) Paolo Gelosa et al. PHARMACOLOGICAL RESEARCH
- Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation
- (2019) Yohei Kawai et al. Biomed Research International
- Effects of anti-allergic drugs on T cell-mediated nasal hyperresponsiveness in a murine model of allergic rhinitis
- (2018) Tomoe Nishimura et al. ALLERGOLOGY INTERNATIONAL
- Comparison of the effects of nasal steroids and montelukast on olfactory functions in patients with allergic rhinitis
- (2017) A. Dalgic et al. European Annals of Otorhinolaryngology-Head and Neck Diseases
- Therapeutic potential of combined anti-IL-1β IgY and anti-TNF-α IgY in guinea pigs with allergic rhinitis induced by ovalbumin
- (2015) Hu Guo-zhu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?
- (2014) Kam-Lun Ellis Hon et al. Drug Design Development and Therapy
- Efficacy and safety of montelukast add-on therapy in allergic rhinitis
- (2011) P.V. Modgill et al. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
- A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score
- (2010) Niti Sardana et al. ALLERGY AND ASTHMA PROCEEDINGS
- Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma
- (2010) Nathan Rabinovitch et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Phase I Randomized, Placebo-Controlled, Dose-Exploration Study of Single-Dose Inhaled Montelukast in Patients with Chronic Asthma
- (2010) George Philip et al. JOURNAL OF ASTHMA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now